Journal of Internal Medicie and Patient Care

Editor in Chief

Dr. Jagadeesh Kumar Kalavakunta is working as Assistant professor, Dept. of Internal Medicine/Cardiology, Western Michigan University Homer Stryker M.D. School of Medicine, USA. He is a board certified in the Internal Medicine and Cardiology. He received best doctor of the month December award from Sparrow Hospital and many honors in his career. He has 12 years of teaching experience. He is actively…

Name : Jagadeesh Kumar Kalavakunta
University : Western Michigan University

Indexing and Listing



Recent Articles

  • article image

    Pembrolizumab Associated Hypothyroidism: Case Report and Review of Literature

    Pembrolizumab is a Programmed Death 1 (PD-1) inhibitor used to treat advanced malignant melanoma and metastatic non- small cell lung cancer. It was recently approved by United States Food and Drug Administration (FDA) for treatment of unresectable and advanced stage malignant melanoma. The most common side effects of Pembrolizumab noted in various…

    View more

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial